Handelsbanken Fonder’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
5,572
-100
| -2% | -$24.1K | ﹤0.01% | 823 |
|
|
2025
Q1 | $1.38M | Hold |
5,672
| – | – | 0.01% | 808 |
|
|
2024
Q4 | $1.86M | Buy |
5,672
+400
| +8% | +$131K | 0.01% | 703 |
|
|
2024
Q3 | $1.76M | Buy |
5,272
+900
| +21% | +$301K | 0.01% | 711 |
|
|
2024
Q2 | $1.19M | Hold |
4,372
| – | – | 0.01% | 759 |
|
|
2024
Q1 | $1.51M | Hold |
4,372
| – | – | 0.01% | 686 |
|
|
2023
Q4 | $1.41M | Hold |
4,372
| – | – | 0.01% | 664 |
|
|
2023
Q3 | $1.57M | Hold |
4,372
| – | – | 0.01% | 595 |
|
|
2023
Q2 | $1.66M | Sell |
4,372
-200
| -4% | -$75.8K | 0.01% | 580 |
|
|
2023
Q1 | $2.19M | Buy |
4,572
+1,500
| +49% | +$719K | 0.01% | 519 |
|
|
2022
Q4 | $1.29M | Hold |
3,072
| – | – | 0.01% | 588 |
|
|
2022
Q3 | $1.28M | Hold |
3,072
| – | – | 0.01% | 591 |
|
|
2022
Q2 | $1.52M | Sell |
3,072
-400
| -12% | -$198K | 0.01% | 579 |
|
|
2022
Q1 | $1.96M | Hold |
3,472
| – | – | 0.01% | 587 |
|
|
2021
Q4 | $2.62M | Sell |
3,472
-400
| -10% | -$302K | 0.01% | 564 |
|
|
2021
Q3 | $2.89M | Buy |
3,872
+400
| +12% | +$298K | 0.02% | 559 |
|
|
2021
Q2 | $2.24M | Sell |
3,472
-300
| -8% | -$193K | 0.01% | 606 |
|
|
2021
Q1 | $2.15M | Hold |
3,772
| – | – | 0.01% | 591 |
|
|
2020
Q4 | $2.2M | Buy |
3,772
+500
| +15% | +$291K | 0.01% | 591 |
|
|
2020
Q3 | $1.69M | Buy |
3,272
+200
| +7% | +$103K | 0.01% | 594 |
|
|
2020
Q2 | $1.39M | Buy |
+3,072
| New | +$1.39M | 0.01% | 602 |
|